$2.01
0.063.08%
Aytu BioPharma Inc
AYTUNASDAQ
Aytu BioPharma (AYTU) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.32 | $-0.40 | $-0.40 | $-0.14 |
| Actual | $0.00 | $-0.53 | $-1.05 | $-0.08 |
| Surprise | +100.0% | -32.5% | -162.5% | +42.9% |
| Revenue | ||||
| Estimate | $12.1M | $12.0M | $12.1M | $12.6M |
| Actual | $16.1M | $12.4M | $15.2M | $13.9M |
| Surprise | +32.8% | +3.06% | +25.2% | +10.3% |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.16 | $-0.13 | $-0.04 | $0.06 |
| Revenue | ||||
| Consensus | $13.5M | $15.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Sep 22, 2026 | $0 | $-0.32 | 100.0 % |
| Q3 | May 13, 2026 | $-0.53 | $-0.40 | -32.5 % |
| Q2 | Feb 3, 2026 | $-1.05 | $-0.40 | -162.5 % |
| Q1 | Nov 13, 2025 | $-0.08 | $-0.14 | 42.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Sep 22, 2026 | $16.11M | $12.13M | 32.8 % |
| Q3 | May 13, 2026 | $12.41M | $12.04M | 3.06 % |
| Q2 | Feb 3, 2026 | $15.17M | $12.11M | 25.2 % |
| Q1 | Nov 13, 2025 | $13.90M | $12.61M | 10.3 % |
